Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.

Fabbri, Alberto

Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up. [electronic resource] - Hematological oncology Dec 2013 - 213-7 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

1099-1069

10.1002/hon.2038 doi


Angiogenesis Inhibitors--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Clinical Trials as Topic--statistics & numerical data
Combined Modality Therapy
Cytarabine--administration & dosage
Deoxycytidine--administration & dosage
Dexamethasone--administration & dosage
Doxorubicin--administration & dosage
Drug Resistance, Neoplasm
Drugs, Investigational--therapeutic use
Follow-Up Studies
Humans
Ifosfamide--administration & dosage
Immunologic Factors--therapeutic use
Lenalidomide
Lymphoma, T-Cell, Peripheral--drug therapy
Male
Middle Aged
Organoplatinum Compounds--administration & dosage
Polyethylene Glycols--administration & dosage
Prednisone--administration & dosage
Remission Induction
Salvage Therapy
Thalidomide--analogs & derivatives
Vinblastine--administration & dosage
Vinorelbine
Gemcitabine